Clinical & Experimental Allergy · 1990 · 32 citations · 13 references
Life SciencesPharmacologyPharmacotherapyAllergyHypersensitivityOcular PharmacologyAllergen ImmunotherapyAllergic ConjunctivitisAllergy PharmacotherapyDrug AllergyPollen AllergyAllergic Conjunctivitis ManagementAllergic Conjunctivitis PharmacotherapyConjunctival Allergen ChallengeConjunctival Provocation TestingConjunctivitis ProphylaxisPollen Immunotherapy
Cetirizine is a new selective H1-antagonist. In a double-blind and placebo-controlled study, 11 subjects underwent a conjunctival provocation test (CPT) with a grass pollen extract to determine the effect of cetirizine on allergen-induced itching and redness of the eye. Results of CPTs were reproducible, as no difference was observed between the CPTs performed without any pre-treatment and the CPTs after placebo. Compared to placebo, cetirizine administered orally (10 mg twice a day for 4 days) and in double-blind fashion increased the conjunctival reaction threshold (P less than 0.004) by inhibiting both redness and itching of the eye. Cetirizine should protect patients against allergic conjunctivitis.
13
PROPHYLACTIC INOCULATION AGAINST HAY FEVER
L. Noon · The Lancet · 1911 · 1.4K citations
The Precision of the Conjunctival Provocation Test
Christian Möller, Bengt Björkstén, Göran Nilsson et al. · Allergy · 1984 · 166 citations
Receptor effects of cetirizine.
Snyder Sh, Snowman Am · PubMed · 1987 · 126 citations
Lennart Juhlin, C. de Vos, J.‐P. Rihoux · Journal of Allergy and Clinical Immunology · 1987 · 78 citations · Full text